MARKET

AMRN

AMRN

Amarin
NASDAQ
14.69
+0.05
+0.34%
Closed 16:00 04/07 EDT
OPEN
14.59
PREV CLOSE
14.64
HIGH
14.79
LOW
14.23
VOLUME
35.66K
TURNOVER
0
52 WEEK HIGH
20.90
52 WEEK LOW
7.52
MARKET CAP
305.61M
P/E (TTM)
-7.8560
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AMRN last week (0330-0403)?
Weekly Report · 2d ago
Weekly Report: what happened at AMRN last week (0323-0327)?
Weekly Report · 03/30 09:25
Amarin Streamlines Board, Updates Director Equity Compensation Plan
TipRanks · 03/27 22:27
Amarin board shrinks to seven directors; Paul Cohen and Oliver O'Connor exit ahead of 2026 annual meeting
Reuters · 03/27 21:01
Weekly Report: what happened at AMRN last week (0316-0320)?
Weekly Report · 03/23 09:24
Amarin highlights new recommendation for treatment of CV risk
TipRanks · 03/18 12:41
Amarin Highlights 2026 ACC/AHA Dyslipidemia Guideline Emphasizing CV Risk Management In Hypertriglyceridemia
Benzinga · 03/18 12:33
Amarin cites 2026 ACC/AHA dyslipidemia guideline support for icosapent ethyl in statin-treated patients with elevated triglycerides
Reuters · 03/18 12:32
More
About AMRN
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

Webull offers Amarin Corporation PLC stock information, including NASDAQ: AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRN stock methods without spending real money on the virtual paper trading platform.